Molina Healthcare, Inc. (NYSE:MOH) Stock Position Increased by Federated Hermes Inc.

Federated Hermes Inc. boosted its position in shares of Molina Healthcare, Inc. (NYSE:MOH) by 0.4% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 82,860 shares of the company’s stock after buying an additional 321 shares during the period. Federated Hermes Inc.’s holdings in Molina Healthcare were worth $29,938,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently bought and sold shares of MOH. Desjardins Global Asset Management Inc. boosted its position in shares of Molina Healthcare by 4.4% during the 4th quarter. Desjardins Global Asset Management Inc. now owns 763 shares of the company’s stock valued at $276,000 after purchasing an additional 32 shares in the last quarter. Ritholtz Wealth Management boosted its holdings in Molina Healthcare by 2.1% during the fourth quarter. Ritholtz Wealth Management now owns 1,620 shares of the company’s stock worth $585,000 after buying an additional 33 shares in the last quarter. Captrust Financial Advisors grew its position in Molina Healthcare by 0.5% in the second quarter. Captrust Financial Advisors now owns 6,315 shares of the company’s stock worth $1,766,000 after buying an additional 33 shares during the last quarter. New York Life Investment Management LLC increased its holdings in shares of Molina Healthcare by 0.4% in the third quarter. New York Life Investment Management LLC now owns 8,495 shares of the company’s stock valued at $2,785,000 after buying an additional 36 shares in the last quarter. Finally, Aptus Capital Advisors LLC lifted its position in shares of Molina Healthcare by 5.0% during the 3rd quarter. Aptus Capital Advisors LLC now owns 763 shares of the company’s stock valued at $250,000 after acquiring an additional 36 shares during the last quarter. 98.50% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In related news, Director Richard M. Schapiro sold 711 shares of the company’s stock in a transaction dated Monday, February 12th. The shares were sold at an average price of $384.06, for a total value of $273,066.66. Following the sale, the director now owns 12,207 shares in the company, valued at approximately $4,688,220.42. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. In other news, CFO Mark Lowell Keim sold 15,000 shares of the company’s stock in a transaction dated Monday, February 12th. The stock was sold at an average price of $386.56, for a total transaction of $5,798,400.00. Following the sale, the chief financial officer now directly owns 36,531 shares in the company, valued at $14,121,423.36. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, Director Richard M. Schapiro sold 711 shares of the company’s stock in a transaction dated Monday, February 12th. The stock was sold at an average price of $384.06, for a total value of $273,066.66. Following the completion of the transaction, the director now owns 12,207 shares in the company, valued at $4,688,220.42. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 16,711 shares of company stock worth $6,472,517. Corporate insiders own 1.10% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts recently issued reports on MOH shares. Cantor Fitzgerald restated an “overweight” rating and issued a $406.00 target price on shares of Molina Healthcare in a report on Thursday, April 4th. Wells Fargo & Company reduced their target price on Molina Healthcare from $440.00 to $410.00 and set an “equal weight” rating for the company in a report on Monday, April 15th. Barclays started coverage on shares of Molina Healthcare in a report on Wednesday, March 6th. They set an “equal weight” rating and a $437.00 price target for the company. Bank of America downgraded Molina Healthcare from a “neutral” rating to an “underperform” rating and set a $439.00 target price on the stock. in a research report on Thursday, March 28th. Finally, Truist Financial increased their price objective on shares of Molina Healthcare from $435.00 to $460.00 and gave the company a “buy” rating in a research note on Tuesday, February 20th. One analyst has rated the stock with a sell rating, four have given a hold rating and five have issued a buy rating to the company’s stock. According to MarketBeat.com, Molina Healthcare has an average rating of “Hold” and an average price target of $393.09.

Molina Healthcare Trading Up 1.8 %

Shares of Molina Healthcare stock opened at $367.52 on Friday. Molina Healthcare, Inc. has a 12-month low of $266.35 and a 12-month high of $423.92. The firm’s 50-day moving average price is $394.33 and its two-hundred day moving average price is $370.95. The company has a quick ratio of 1.54, a current ratio of 1.54 and a debt-to-equity ratio of 0.57. The company has a market capitalization of $21.53 billion, a price-to-earnings ratio of 19.57, a PEG ratio of 1.03 and a beta of 0.47.

Molina Healthcare (NYSE:MOH) last announced its earnings results on Wednesday, February 7th. The company reported $4.38 EPS for the quarter, beating the consensus estimate of $4.31 by $0.07. The business had revenue of $9.05 billion for the quarter, compared to analysts’ expectations of $8.35 billion. Molina Healthcare had a return on equity of 32.34% and a net margin of 3.20%. The firm’s revenue was up 10.0% on a year-over-year basis. During the same period in the prior year, the business posted $4.10 earnings per share. On average, analysts forecast that Molina Healthcare, Inc. will post 23.62 earnings per share for the current fiscal year.

Molina Healthcare Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.